EV/EBITDA
-15.06
+0.26+1.70%
2 min ago
Summary
- As of February 7, 2025, AKRO EV/EBITDA is -15.06, with a rise of +0.26 (+1.70%) during the most recent trading day.
- Over the past year, AKRO EV/EBITDA has dropped by -9.69 (-180.45%).
- AKRO EV/EBITDA is now -1187.18% below its all-time high of -1.17.
Performance
AKRO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
AKRO EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +1.7% | -1.7% | -1.5% |
| 1 m1 month | -126.5% | +126.4% | +107.1% |
| 3 m3 months | -55.4% | +55.5% | +49.4% |
| 6 m6 months | -120.2% | +156.2% | +129.3% |
| ytdytd | -116.1% | +116.2% | +99.1% |
| 1 y1 year | -180.4% | +339.2% | +200.6% |
| 5 y5 years | -1.0% | +415.2% | +107.9% |
AKRO EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -181.5% | -15.84 | +4.9% | |
| 3 m | 3-month | -5.35 | -181.5% | -15.84 | +4.9% |
| 6 m | 6-month | -5.35 | -181.5% | -15.84 | +4.9% |
| 1 y | 1-year | -3.86 | -290.2% | -15.84 | +4.9% |
| 3 y | 3-year | -1.17 | -1187.2% | -26.86 | +43.9% |
| 5 y | 5-year | -1.17 | -1187.2% | -26.86 | +43.9% |
| alltime | all time | -1.17 | -1187.2% | -38.76 | +61.1% |
Akero Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -15.06(+116.1%) |
| 2024 | -6.97(-5.7%) |
| 2023 | -7.39(-64.7%) |
| Date | Value |
|---|---|
| 2022 | -20.92(+257.6%) |
| 2021 | -5.85(-34.0%) |
| 2020 | -8.87(-28.9%) |
| 2019 | -12.47 |
FAQ
- What is Akero Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Akero Therapeutics?
- What is AKRO EV/EBITDA year-to-date change?
- What is Akero Therapeutics EV/EBITDA year-on-year change?
What is Akero Therapeutics EV/EBITDA?
The current EV/EBITDA of AKRO is -15.06
What is the all time high EV/EBITDA for Akero Therapeutics?
Akero Therapeutics all-time high EV/EBITDA is -1.17
What is AKRO EV/EBITDA year-to-date change?
Akero Therapeutics EV/EBITDA has changed by -8.09 (-116.07%) since the beginning of the year
What is Akero Therapeutics EV/EBITDA year-on-year change?
Over the past year, AKRO EV/EBITDA has changed by -9.69 (-180.45%)